Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model.
Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model.
复制标题
DOI:
10.1186/1476-4598-7-20
复制
发表时间:
2008-02-14
期刊:
影响因子:
37.3
通讯作者:
Mohammad RM
中科院分区:
文献类型:
--
作者:
Arnold AA;Aboukameel A;Chen J;Yang D;Wang S;Al-Katib A;Mohammad RM
Elevated expression of anti-apoptotic Bcl-2 family proteins have been linked to a poor survival rate of patients with Follicular Lymphoma (FL). This prompted us to evaluate a very potent non-peptidic Small-Molecule Inhibitor (SMI) targeting Bcl-2 family proteins, Apogossypolone (ApoG2) using follicular small cleaved cell lymphoma cell line (WSU-FSCCL) and cell isolated from lymphoma patients. ApoG2 inhibited the growth of WSU-FSCCL significantly with a 50% growth inhibition of cells (IC50) of 109 nM and decreased cell number of fresh lymphoma cells. ApoG2 activated caspases-9, -3, and -8, and the cleavage of Poly (ADP-ribose) polymerase (PARP) and Apoptosis Inducing Factor (AIF). In the WSU-FSCCL-SCID xenograft model, ApoG2 showed a significant anti-lymphoma effect, with %ILS of 84% in the intravenous and 63% in intraperitoneal treated mice. These studies suggest that ApoG2 can be an effective therapeutic agent against FL.
登录
查看更多内容
影响因子:
45.3
作者:
Fisher, RI;LeBlanc, M;Miller, TP
通讯作者:
Miller, TP
影响因子:
6.5
作者:
Ramanarayanan, J;Hernandez-Ilizaliturri, FJ;Czuczman, MS
通讯作者:
Czuczman, MS
影响因子:
64.8
作者:
Muchmore, SW;Sattler, M;Fesik, SW
通讯作者:
Fesik, SW
影响因子:
11.5
作者:
Mohammad, Ramzi M.;Goustin, Anton Scott;Al-Katibl, Ayad
通讯作者:
Al-Katibl, Ayad
影响因子:
7.3
作者:
Bruncko, Milan;Oost, Thorsten K.;Elmore, Steven W.
通讯作者:
Elmore, Steven W.